• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aiforia H2’25: Green shoots on the clinical side

AIFORIA2026-03-16 10:29
Antti Siltanen, Isa Hudd
Discuss

Aiforia’s H2 revenue growth originated in Europe, where the company has successfully promoted the adoption of clinical models. The digital pathology market has developed more slowly than expected, and the investment's risk profile remains high. Analyst Antti Siltanen summarizes.

Stay up to date
Analyst Interviews

Upcoming webcasts

Recent videos

Aspo Oyj, Webcast, Q2'26
2026-08-03 11:00 Aspo
Incap Q2’26: Utmaningar: Marginalpress och råmaterialbrist
2026-07-30 14:00 Incap
Outokumpu, Webcast, Q2'26
2026-07-30 13:30 Outokumpu
Incap Q2’26: Margins and raw material availability as challenges
2026-07-30 13:04 Incap
Ís
Islandsbanki, Webcast, Q2'26
2026-07-30 10:30 Íslandsbanki
View all videos